Zolpidem Tartrate Sublingual Tablet
Product Images NDC 49884-899

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate Sublingual (NDC 49884-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 1)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 10)

NDC 49884-899-52 is a sublingual tablet of zolpidem tartrate distributed by Par Pharmaceutical. The package includes a blister that can be pushed through from the other side to access the tablets. The tablet is designed to be placed under the tongue to dissolve. The product is made in India and distributed from Chestnut Ridge, NY 10977 U.S.A. The code BL899-52-74-01 is also included on the package. No further information is available from the text provided.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 11)

This text provides instructions for opening and taking Zolpidem Tartrate Sublingual Tablets, a medication used for insomnia. It advises to read the medication guide before use, and to take only one tablet per night if needed. The tablet should be placed under the tongue and allowed to disintegrate before swallowing. The text also includes a dosing time chart to determine when to take the medication based on the desired wake-up time. It provides guidance on properly storing the medication and warnings to only take it if there is enough time left before bedtime.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 12)

This is a medication package for Zolpidem Tartrate Sublingual Tablets. Each sublingual tablet contains 3.5mg of Zolpidem tartrate. The package includes instructions for use, dosage, and storage. The tablet is intended for sublingual administration only and should not be swallowed whole. The package contains a dosing time chart to determine the latest time to take the medication based on the time one needs to wake up. The medication should be stored at room temperature, and the package should be kept out of reach of children. Lot number and expiration date are not available in the given text.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 13)

This is a medication package for a sublingual tablet containing 1.75mg of Zolpidem Tartrate. The package includes 30 unit-dose pouches, and each pouch has one sublingual tablet. The product is intended for sublingual administration only, and one should not swallow the tablet whole. The package includes medication guide and dosing time tool which should be dispensed with each patient. The usual adult dosage is not available as it's mentioned in the missing dosing time tool. The storage temperature is also specified on the package. Additionally, the package warns to keep the tablets and drugs out of children's reach. The manufacturer is Par Formulations Limited.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 14)

This text is a description of a medication, likely Zolpidem Tartrate, sold in a pouch containing one sublingual tablet. Each tablet contains 3.5 mg of the medication and should be taken by placing it under the tongue. The medication is to be kept away from children, and the pharmacist is required to dispense the medication guide and dosing time tool to each patient. The medication guide can be accessed at www.parpharm.com.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 15)

This is a medication label for Zolpidem Tartrate Sublingual Tablet. It provides instructions on how to take the medication correctly, including finding the latest dosing time and ensuring that at least 4 hours of bedtime is available before taking the medication. It also includes a product code at the bottom of the label.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 2)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 3)

This text provides dosing instructions for a medication called zolpidem tartrate sublingual tablet. It lists the times at which the medication should be taken if the user needs to be awake at specific times, ranging from before 4 am to 9 am. The instructions are presented in a table, with the times organized in two columns and six rows. The text also includes a reference to "Figure B," although it is unclear what this image represents without further information.*

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 4)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 5)

FDA Label Image

Zoplidem (Zolpidem Tartrate Sublingual Tablets 6)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 7)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 8)

FDA Label Image

Zolpidem (Zolpidem Tartrate Sublingual Tablets 9)

This is a medication package for Zolpidem Tartrate, a sublingual tablet used for treating insomnia. It contains 1.75 mg of the active ingredient and is distributed by Par Pharmaceuticals in Chestnut Ridge, NY. The tablet should be pushed through the blister packaging from the opposite side. The package has a unique identifier code of NDC 49884-898-52 and was made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.